Overall, our study identifies BCL6 as a pivotal transcriptional regulator, which, when lost in T cells, limits anti-insulin B cell activation, proliferation, IgG class switching, GC B cell differentiation, and skewing into the CD11b+ CD11c+ atypical B cell subset in T1D. This evidence concerns the gene BCL6 and type 1 diabetes mellitus.